BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2294105)

  • 1. Formation of a ternary complex between thrombin, fibrin monomer, and heparin influences the action of thrombin on its substrates.
    Hogg PJ; Jackson CM
    J Biol Chem; 1990 Jan; 265(1):248-55. PubMed ID: 2294105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin promotes the binding of thrombin to fibrin polymer. Quantitative characterization of a thrombin-fibrin polymer-heparin ternary complex.
    Hogg PJ; Jackson CM
    J Biol Chem; 1990 Jan; 265(1):241-7. PubMed ID: 2294104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of heparin activity in plasma by soluble fibrin: evidence for ternary thrombin-fibrin-heparin complex formation.
    Hotchkiss KA; Chesterman CN; Hogg PJ
    Blood; 1994 Jul; 84(2):498-503. PubMed ID: 8025278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of fibrin monomer and heparin to thrombin in a ternary complex alters the environment of the thrombin catalytic site, reduces affinity for hirudin, and inhibits cleavage of fibrinogen.
    Hogg PJ; Jackson CM; Labanowski JK; Bock PE
    J Biol Chem; 1996 Oct; 271(42):26088-95. PubMed ID: 8824251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the kinetic pathway for liberation of fibrinopeptides during assembly of fibrin.
    Lewis SD; Shields PP; Shafer JA
    J Biol Chem; 1985 Aug; 260(18):10192-9. PubMed ID: 4019507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A; Di Cera E
    Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombin cleavage enhances exposure of a heparin binding domain in the N-terminus of the fibrin beta chain.
    Odrljin TM; Shainoff JR; Lawrence SO; Simpson-Haidaris PJ
    Blood; 1996 Sep; 88(6):2050-61. PubMed ID: 8822924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steady state kinetic parameters for the thrombin-catalyzed conversion of human fibrinogen to fibrin.
    Higgins DL; Lewis SD; Shafer JA
    J Biol Chem; 1983 Aug; 258(15):9276-82. PubMed ID: 6409903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of fibrin polymerization by fragment d is affected by calcium, Gly-Pro-Arg and Gly-His-Arg.
    Furlan M; Rupp C; Beck EA
    Biochim Biophys Acta; 1983 Jan; 742(1):25-32. PubMed ID: 6824684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of fibrin-bound thrombin by a covalent antithrombin-heparin complex.
    Berry LR; Becker DL; Chan AK
    J Biochem; 2002 Aug; 132(2):167-76. PubMed ID: 12153711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin binds to soluble fibrin degradation products where it is protected from inhibition by heparin-antithrombin but susceptible to inactivation by antithrombin-independent inhibitors.
    Weitz JI; Leslie B; Hudoba M
    Circulation; 1998 Feb; 97(6):544-52. PubMed ID: 9494024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy.
    Hogg PJ; Jackson CM
    Proc Natl Acad Sci U S A; 1989 May; 86(10):3619-23. PubMed ID: 2726739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for multiple enzyme site involvement in the modulation of thrombin activity by products of prothrombin proteolysis.
    Shi F; Hogg PJ; Winzor DJ; Jackson CM
    Biophys Chem; 1998 Dec; 75(3):187-99. PubMed ID: 9894338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidation of human alpha-thrombin by the myeloperoxidase-H2O2-chloride system: structural and functional effects.
    De Cristofaro R; Landolfi R
    Thromb Haemost; 2000 Feb; 83(2):253-61. PubMed ID: 10739383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interaction of fibrinogen with two forms of fibrin differing in the degree of activation by thrombin].
    Belitser VA; Lugovskoĭ EV; Ugarova TP; Derzskaia SG
    Biokhimiia; 1985 Aug; 50(8):1336-41. PubMed ID: 4074798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline.
    Nossel HL; Wasser J; Kaplan KL; LaGamma KS; Yudelman I; Canfield RE
    J Clin Invest; 1979 Nov; 64(5):1371-8. PubMed ID: 500818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots.
    Weisel JW; Veklich Y; Gorkun O
    J Mol Biol; 1993 Jul; 232(1):285-97. PubMed ID: 8331664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion of fibrinogen to fibrin induced by preferential release of fibrinopeptide B.
    Dyr JE; Blombäck B; Hessel B; Kornalík F
    Biochim Biophys Acta; 1989 Jan; 990(1):18-24. PubMed ID: 2914147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of protons on the thrombin-fibrinogen interaction.
    Picozzi M; Landolfi R; De Cristofaro R
    Eur J Biochem; 1994 Feb; 219(3):1013-21. PubMed ID: 8112314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin-fibrinogen interaction: pH dependence and effects of the slow-->fast transition.
    Mathur A; Schlapkohl WA; Di Cera E
    Biochemistry; 1993 Jul; 32(29):7568-73. PubMed ID: 8393345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.